ANTIKÖRPERMOLEKÜLE MIT BINDUNG VON CD45

Patent europeic · EP3322729 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3322729
Numer da la dumonda
EP16740998
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-07-2016
Publitgà
23-05-2018
Concedì
09-09-2026
La protecziun finescha il pli tard
14-07-2036
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 16/28 (2006.01)
C07K 16/18 (2006.01)
A61K 45/06 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/02 (2006.01)
A61P 37/04 (2006.01)
A61P 43/00 (2006.01)
Prioritad
WO PCT/EP2015/066368 16.07.2015
GB 201601073 20.01.2016
Dumonda PCT
PCT/EP2016/066987 15.07.2016
Publicaziun PCT
WO2017/009473 19.01.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 11-09-2026

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 11.09.2026

  2. 09-09-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.09.2026

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

FINNEY, Helene Margaret

Slough Berkshire SL1 3WE, GB

RAPECKI, Stephen Edward

Slough Berkshire SL1 3WE, GB

TYSON, Kerry Louise

Slough Berkshire SL1 3WE, GB

WRIGHT, Michael John

Slough Berkshire SL1 3WE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.